AQST - Aquestive Therapeutics Inc
IEX Last Trade
4.52
0.120 2.655%
Share volume: 892,930
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$4.40
0.12
2.73%
Fundamental analysis
44%
Profitability
41%
Dept financing
37%
Liquidity
75%
Performance
40%
Performance
5 Days
1.57%
1 Month
19.21%
3 Months
55.67%
6 Months
24.11%
1 Year
174.55%
2 Year
198.03%
Key data
Stock price
$4.52
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.25 - $6.23
52 WEEK CHANGE
$1.71
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO:
Region: US
Website: aquestive.com
Employees: 111
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: aquestive.com
Employees: 111
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. our initial focus, supported by our current approved products and late stage pipeline, is to address immediate cns challenges.
Recent news